Endocrine therapy monitored by hormone cytological examination in advanced female breast cancer
Iglódi, F.
Therapia Hungarica 37(4): 205-208
1989
ISSN/ISBN: 0133-3909 PMID: 2631288 Document Number: 337068
Endocrine polychemotherapy of advanced breast cancer of women was monitored by vaginal hormone receptor cytological examinations and hormone receptor assay. The methods, results and endocrinological observations of the authors have been described. The revision of the indication field of antioestrogen therapy is suggested.
Document emailed within 1 workday
Related Documents
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Tachibana, K.; Ohtake, T.; Saji, S. 2016: III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512
Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Bhatavdekar, J.M.; Shah, N.G.; Patel, D.D.; Karelia, N.H.; Trivedi, S.N.; Vora, H.H.; Ghosh, N.; Giri, D.D.; Balar, D.B. 1992: Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen Neoplasma 39(2): 123-127
Pannuti, F.; Martoni, A.; Farabegoli, G.; Piana, E. 1985: Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 4(2): 127-134
Fazio, M.; Cavallero, P.; Rattalino, G.; Sartoris, S.; Vergnano, F. 1976: Combination drug-hormone therapy of the advanced stages of breast carcinoma Minerva Ginecologica 28(7-8): 623-629
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Howell, A.; Harland, R.N.; Barnes, D.M.; Baildam, A.D.; Wilkinson, M.J.; Hayward, E.; Swindell, R.; Sellwood, R.A. 1987: Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment Cancer Research 47(1): 300-304
Jonat, W.; Maass, H. 1987: Endocrine therapy of breast cancer Zentralblatt für Gynakologie 109(10): 617-627
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135
Yoshida, M.; Miura, S. 1984: Internal endocrine therapy of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 989-998
Stepanenko, M.A. 1980: Organization of a cytological examination of the female population Laboratornoe Delo 9: 538-540